Prognostic value of serum CRP, IgM and IgA levels in children with Mycoplasma pneumoniae and pleural effusion

serum CRP, IgM and IgA levels in children with Mycoplasma pneumoniae

  • Huiqing Guo 1. Department of Pediatrics, Children's Hospital of Shanxi and Women’s Health Center of Shanxi, Taiyuan City, 030013, Shanxi Province, China
DOI: https://doi.org/10.5937/jomb0-54947
Ključne reči: 0

Sažetak


0

Reference

[1]Chiu, C.-Y., Chiang, L.-M., & Chen, T.-P. (2006). Mycoplasma pneumoniae infection complicated by necrotizing pneumonitis with massive pleural effusion. European journal of pediatrics, 165, 275-277.
[2]Cho, Y. J., Han, M. S., Kim, W. S., Choi, E. H., Choi, Y. H., Yun, K. W., Lee, S., Cheon, J.-E., Kim, I.-O., & Lee, H. J. (2019). Correlation between chest radiographic findings and clinical features in hospitalized children with Mycoplasma pneumoniae pneumonia. PLoS One, 14(8), e0219463.
[3]Han, C., Zhang, T., Zheng, J., Jin, P., Zhang, Q., Guo, W., & Xu, Y. (2022). Analysis of the risk factors and clinical features of Mycoplasma pneumoniae pneumonia with embolism in children: a retrospective study. Italian Journal of Pediatrics, 48(1), 1-11.
[4]Kim, S.-H., Lee, E., Song, E.-S., & Lee, Y.-Y. (2021). Clinical significance of pleural effusion in mycoplasma pneumoniae pneumonia in children. Pathogens, 10(9), 1075.
[5]Lee, K.-L., Lee, C.-M., Yang, T.-L., Yen, T.-Y., Chang, L.-Y., Chen, J.-M., Lee, P.-I., Huang, L.-M., & Lu, C.-Y. (2021). Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010–2019. Journal of the Formosan Medical Association, 120(1), 281-291.
[6]Ling, Y., Zhang, T., Guo, W., Zhu, Z., Tian, J., Cai, C., & Xu, Y. (2020). Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children. BMC Infectious Diseases, 20, 1-8.
[7]Medjo, B., Atanaskovic-Markovic, M., Radic, S., Nikolic, D., Lukac, M., & Djukic, S. (2014). Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis. Italian Journal of Pediatrics, 40, 1-7.
[8]Nagayama, Y., Sakurai, N., & Yamamoto, K. (1990). Clinical observations of children with pleuropneumonia due to Mycoplasma pneumoniae. Pediatric pulmonology, 8(3), 182-187.
[9]Søndergaard, M. J., Friis, M. B., Hansen, D. S., & Jørgensen, I. M. (2018). Clinical manifestations in infants and children with Mycoplasma pneumoniae infection. PLoS One, 13(4), e0195288.
[10]Song, S., & Xu, Y. (2023). A retrospective study of the clinical characteristics of 9 children with pulmonary embolism associated with Mycoplasma pneumoniae pneumonia. BMC pediatrics, 23(1), 370.
[11]Su, D.-Q., Li, J.-F., & Zhuo, Z.-Q. (2020). Clinical analysis of 122 cases with mycoplasma pneumonia complicated with atelectasis: a retrospective study. Advances in therapy, 37, 265-271.
[12]Vervloet, L. A., Camargos, P. A. M., Soares, D. R. F., Oliveira, G. A. d., & Oliveira, J. N. d. (2010). Clinical, radiographic and hematological characteristics of Mycoplasma pneumoniae pneumonia. Jornal de Pediatria, 86, 480-487.
[13]Vervloet, L. A., Vervloet, V. E. C., Tironi Junior, M., & Ribeiro, J. D. (2012). Mycoplasma pneumoniae-related community-acquired pneumonia and parapneumonic pleural effusion in children and adolescents. Jornal Brasileiro de Pneumologia, 38, 226-236.
[14]Wang, J., Xia, C., Sharma, A., Gaba, G. S., & Shabaz, M. (2021). Chest CT findings and differential diagnosis of mycoplasma pneumoniae pneumonia and mycoplasma pneumoniae combined with streptococcal pneumonia in children. Journal of Healthcare Engineering, 2021.
[15] Wang Guanling, Hu Binfei. Risk factors analysis of pleural effusion in hospitalized children with mycoplasma pneumoniae pneumonia [J]. Journal of Medical Research,2017,46(02):142-144.
[16] Zheng Baoying, Yan Chao, Xue Guanhua, et al. Analysis of clinical characteristics and epidemic genotypes in children with drug-resistant mycoplasma pneumoniae pneumonia [J]. Chinese Journal of Practical Pediatrics, 2017, 32(10): 735 -- 739.
[17] YAN C, XUE G, ZHAO H, et al. Molecular and Clinical Characteristics of Severe Mycoplasma Pneumoniae Pneumonia in Children[J]. Pediatric Pulmonology, 2019,54(7):1012–1021.
[18] Ling, Y., Zhang, T., Guo, W., Zhu, Z., Tian, J., Cai, C., & Xu, Y. (2020). Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children. BMC Infectious Diseases, 20. https://doi.org/10.1186/s12879-020-05270-6.
[19] Lee, E., & Lee, Y. (2021). Predictive Factors of the Responses to Treatment of Mycoplasma pneumoniae Pneumonia. Journal of Clinical Medicine, 10. https://doi.org/10.3390/jcm10061154.
Objavljeno
2025/04/08
Broj časopisa
Vol. 44 Br. 6 (2025): Journal of Medical Biochemistry
Rubrika
Original paper

Sva prava zadržana (c) 2025 Chao Chen

Creative Commons License

Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.